Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler  by Rubio, Nazario & Sanz-Rodriguez, Francisco
07) 98–108
www.elsevier.com/locate/yviroVirology 358 (20Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection
with the murine encephalomyelitis virus of Theiler
Nazario Rubio a,⁎, Francisco Sanz-Rodriguez b
a Instituto Cajal, C.S.I.C., Dr. Arce Avenue 37, 28002 Madrid, Spain
b Department of Biology, Universidad Autonoma de Madrid, Spain
Received 9 May 2006; returned to author for revision 28 July 2006; accepted 2 August 2006
Available online 22 September 2006Abstract
In the present study, we focused on the production of the chemokine CXCL1, also termed KC, by cultured Theiler murine encephalomyelitis
virus (TMEV)-infected mouse astrocytes. cRNA from mock- and TMEV-infected cells was hybridized to the Affymetrix murine genome U74v2
DNA microarray. Hybridization data analysis demonstrated upregulation of two sequences coding for IL-8 and related to the GRO 1 oncogene
MGSA. The murine counterpart of the above human genes has been reported to be the chemokine CXCL1 or KC, and therefore we studied its
regulation, confirming its mRNA increase by Northern blots. The presence of CXCL1 in the supernatants of infected cells was further
demonstrated by a specific ELISA and its intracellular accumulation by flow cytometry. This secreted CXCL1 was biologically active in a non
species-specific way as it induces chemoattraction on human neutrophils and monocyte/macrophages, but not on CD3 positive lymphocytes. Its
induction does not follow the MAP kinase pathway which transcripts are decrease in infected cells compared with uninfected astrocytes. Two
inflammatory cytokines, IL-1α and TNF-α, which are also induced by TMEV in astrocytes, were potent inducers of CXCL1. Nevertheless, both
mechanisms of induction follow different pathways as antibodies to both cytokines fail to inhibit TMEV-induced CXCL1 upregulation. Spinal
cords but not brains from TMEV-infected SJL/J animals contain CXCL1 at the start of clinical signs of the disease. As no CXCL1 induction can
be detected neither in cultured BALB/c astrocytes nor in nervous tissue, we propose an important role for CXCL1 in this experimental model of
multiple sclerosis as a chemoattractant of destructive immune cells.
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Chemotactic cytokines or chemokines are a family of small
proteins that cause leukocyte migration. Based on the relative
position of its cysteine residues, chemokines have been
classified in four subfamilies. CXCL1 (KC) is a mouse
chemokine belonging to the CXC (C=cystein) mouse che-
mokine family, or α family, of this immunoregulatory cyto-
kines (Schall, 1994). The gene coding for CXCL1 is the
murine homologue of a human oncogene termed GRO,
coding for a “melanome growth-stimulating activity” that was
originally induced in quiescent fibroblasts by platelet-derived
growth factor and bombesin (Cochran et al., 1983; Oquendo
et al., 1989; Ryseck et al., 1989). It codes for a secretory⁎ Corresponding author.
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doi:10.1016/j.virol.2006.08.003protein of 8 kDa that is mainly induced by LPS in macro-
phages and vascular cells (Lira et al., 1994). The primary
sequence of CXCL1 protein shares 63% identity to the mouse
inflammatory protein-2 (MIP-2), another member of the CXC
mouse chemokine family (Oquendo et al., 1989). Both exert
its activity through a unique mouse receptor (Heinrich and
Bravo, 1995) that shows a 68 and 71% amino acid identity to
human IL-8Rα and IL-8Rβ, respectively (Lee et al., 1995).
Therefore, CXCL1 has been proposed as a functional
homologue of human IL-8 and is associated with neutrophil
recruitment and inflammation. Influx of neutrophils from the
blood and its interaction with vascular endothelium at the site
of infection or damage is an early step of acute inflammation
(Godiska et al., 1995).
Theiler's murine encephalomyelitis virus (TMEV) is a
picornavirus that persistently infects the murine central ner-
vous system (CNS) (Theiler, 1937). After intracerebral
99N. Rubio, F. Sanz-Rodriguez / Virology 358 (2007) 98–108inoculation of the BeAn low-neurovirulence strain, suscep-
tible strains of mice develop a chronic demyelinating disease
that is reminiscent of human multiple sclerosis (MS) (Clatch
et al., 1986; Gerety et al., 1994). Myelin breakdown is
mediated by the immune system rather than being a direct
consequence of viral infection of oligodendrocytes, the
myelin forming cell (Clatch et al., 1986; Lipton and Dal
Canto, 1976; Peña Rossi et al., 1991; Roos et al., 1982).
Focal inflammation occurs in the white matter of the brain
and spinal cord, and mononuclear immune cell infiltrates
were observed in demyelinating areas (Clatch et al., 1986).
Therefore, chemokines, charged with recruitment and influx
of immune cells, can be involved in this process and one of
them, the CXCL1 chemokine, was analyzed in the experi-
ments reported in the present article. To determine if genes
coding for chemokines are upregulated in response to
infection by TMEV in astrocytes, the main glial population
in the CNS, we have used cDNA microarray hybridization
technology to perform a large-scale examination of gene
expression. This technology has been useful in the study of
several gene expression patterns. Microarray analysis of gene
expression in SJL/J astrocytic cells identifies a variety of
genes whose mRNA patterns change in response to Theiler's
virus infection, but do not change in sham-infected cells.
Chemokines have been associated with the trafficking of
immune cells in connection with inflammatory cell recruit-
ment in different diseases, including neuroinflammatory
diseases as MS (Asensio and Campbell, 1999). The rationale
of this article is based on the demonstrated fact that
astrocytes are an early component of the immune response
to TMEV and the demonstration of CXCL1 production by
astrocytes from TMEV-susceptible SJL/J but not for the
resistant BALB/c mouse strains. This suggests a crucial role
for this glial population in TMEV-induced demyelination.
Results
TMEV-induced alterations in gene expression
The Affymetrix GeneChip SE437 and SE438 microarray
mouse gene expression analysis reveals that two sequences with a
PFAM (Protein FAMilies) database hit description as “IL-8” have
the UniGene title of “GRO 1 oncogene” and the SCOP
(Structural Classification Of Proteins) description of “melanoma
growth-stimulating activity” (Table 1). Those sequences were notTable 1
UniGene and SCOP described as “GRO 1 oncogene” or “melanoma growth-stimulati
the IL-8 family genes in astrocytes
Affymetrix
sequence
Sham-infected
astrocytes signal
TMEV-infected
astrocytes signal
Signal log
ratio
Fold change C
lo
95,349 g at 10.5 2079.4 7.4 14.8 #5
95,348 at 24.5 3484.1 6.9 13.8 #5
a PFAM=“Proteins FAMily” database.
b SCOP=“Structural Classification Of Proteins” database.expressed in sham-infected astrocytes and exhibit a fold change
of 14.8 and 13.8, respectively, in infected cells. Both were located
in mouse chromosome number 5 and had a GO (Gene Ontology)
database cellular component notation indicating that both are
extracellular and involved in chemotaxis and inflammatory
response. The GRO oncogene codes for a factor named
“melanoma growth-stimulating activity” or MGSA, and it has
been demonstrated as being the human homologue of the gene
coding for the mouse chemokine CXCL1 (Oquendo et al., 1989).
Therefore, our DNA array gene expression analysis indicates an
overexpression of the CXCL1 chemokine that was further
validated and investigated in this article.
TMEV-induced expression of CXCL1 mRNA in astrocytes
In order to study the effect of TMEV infection on CXCL1
mRNA expression, cultured SJL/J astrocytes were infected at
different m.o.i. for 24 h, and total RNA was purified and
analyzed by Northern blots. CXCL1 mRNA levels increased
in a dose-responsive manner, peaking at a m.o.i. of 10.
Transcripts above background could be detected down to a
m.o.i. of 1 (Fig. 1, upper panel). The system seems saturated at
a m.o.i. of 10 as further increases did not augment the levels of
transcription (not shown). When the relative amount of mRNA
was quantified with a Model 300 A computing densitometer
(Molecular Dynamics Inc., Sevenoaks, Kent, UK), it was
shown that the bands obtained after infection at m.o.i. of 1 and
10 were 8 and 20 times more dense as compared to the
background. The probing of BALB/c astrocytes infected in the
same conditions was consistently found negative (not shown).
ELISA and flow cytometry detection of CXCL1
Culture supernatants of SJL/J brain astrocytes infected in vitro
at different m.o.i.s showed high CXCL1 production, as
determined by using the QuantikineR M mouse KC ELISA kit
(Fig. 2A). Supernatants from mock-infected cultures (0), from
cultures infected at an m.o.i. of 0.1 or with UV light-inactivated
BeAn virus failed to show any significant CXCL1 activity.
Maximal CXCL1 levels were detected using an m.o.i. of 10.
When we explored the kinetics of CXCL1 production for periods
ranging from 4 to 48 h, we detected maximal release to the
supernatant after 48 h (Fig. 2B). Astrocytes fromBALB/c mice, a
strain resistant to TMEV demyelination, produce almost
undetectable levels of CXCL1 when infected in the sameng activity” (MGSA) upregulated sequences in the TMEV-induced expression of
hromosome
cation
PFAMa
description
UniGene title SCOPb description
IL-8 GRO 1 oncogene Melanoma growth-stimulating
activity
IL-8 GRO 1 oncogene Melanoma growth-stimulating
activity
Fig. 1. Abundance of CXCL1 mRNA in astrocytes mock-infected (0) or TMEV-
infected at m.o.i.s of 0.1–10, for 24 h, as detected by Northern blot analysis of
10 μg of purified total RNA. Hybridization to the housekeeping gene β-actin
was used as a control for equal RNA loading. The figure is a representative
autoradiograph from three separate experiments.
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the kit is 2.0 pg/ml). To rule out that the BALB/c strain is a poor
producer of CXCL1, we stimulated cultures of peritoneal exudate
cells as a source of macrophages (106 cells per culture) with 1 μg/
ml of LPS for 48 h. BALB/c cells produced similar levels of
CXCL1 to those produced by SJL/J peritoneal cell cultures
(around 60 ng/ml in cultures of both inbred strains). BALB/c
astrocytes are susceptible to infection in the same extent as SJL/J,
both producing titers of around 5–30×105 PFU/ml, as
determined by titration of supernatants on BHK-21 cells
(Rubio et al., 2003).
As shown in Fig. 2C, flow cytometry also demonstrated that
intracellular accumulation of CXCL1 rises from negative
control levels in uninfected astrocytes (thin line histogram) to
positive staining in TMEV-infected cells (black filled histo-
gram). BALB/c astrocytes show negative staining either in
mock- or TMEV-infected cells, in accordance with ELISA
results from Figs. 2A and B (not shown).
Chemotaxis and effect of anti-CXCL1 antibodies
MIP-2-containing astrocyte supernatants from cultures
infected with TMEV attract mouse neutrophils and monocytes
(Rubio et al., 2006). The members of the CXC chemokine
family show no species specificity, being active on cells from
other species. In order to stress that our TMEV-induced
demyelination acts as an experimental model for human
multiple sclerosis, in this article, we have analyzed whetherFig. 2. CXCL1 levels in TMEV-infected astrocyte cultures supernatants as
quantified by ELISA. In panel A, centrifuged supernatants from astrocytes
mock-infected (0) or infected at m.o.i.s of 0.1–10 were tested 48 h after
infection. In panel B, the kinetics of CXCL1 production was measured from 4 to
48 h post-infection at an m.o.i. of 1. Results represent mean values±SD of
triplicate samples. (C) Intracellular levels of CXCL1 in SJL/J astrocytes mock-
infected (thin line histogram) or TMEV-infected for 48 h at a m.o.i. of 10 (black
filled histogram). The appropriate irrelevant antibody negative control staining
is also shown (thick line histogram). Data represent the mean±SD of triplicate
samples. *Significant differences with the unspecific migration control group
were determined by the Student's t test (P<0.01).those supernatants also had a chemotactic activity on human
buffy coat cells. Supernatants from astrocytes containing
around 1000 pg/ml of CXCL1 according with the ELISA
measurements were chosen for those chemotactic experiments.
Undiluted supernatant had a clear chemotactic activity on
human cells (Fig. 3, 0). The positive control was provided by
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potent chemoattractant routinely used as a control in chemotaxis
(Fig. 3, SDF). This chemokine attracts several cell types, mainly
T lymphocytes (Sanz-Rodriguez et al., 2001). We used it to
demonstrate that our supernatants chemoattract other cell
populations different from T-cells, majority in the buffy coat
cell population (see Fig. 4). The supernatants of SJL/J mock-
infected astrocytes as well as of BALB/c infected astrocytes had
no chemoattractant effect on any cell population (not shown).
We next tried to inhibit the action of CXCL1 using neutralizing
antibodies in order to determine the possible contribution of
other redundant chemokines to the observed chemotactic
activity. Antibodies against CXCL1 inhibit chemotaxis (Fig.
3), but around 40% of the activity, measured as number of
migrating cells, cannot be inhibited by increasing amounts of
antibodies going up to 60 μg/ml. Therefore, this activity is
attributed to other chemokines, including MIP-2, present in the
supernatants.
Antigenic characterization of the chemoattracted cell
populations
We further studied the phenotypic characteristics of the
chemoattracted cell populations using the flow cytometer
(Fig. 4). The SDF-1α chemoattracted population (A
population) is composed of 76.4% of T lymphocytes stained
by anti-CD3 antibodies. Concerning the two cell populations
chemoattracted by TMEV-infected SJL/J astrocyte super-
natants (B and C), both populations were stained at 93% by
anti-CD11b antibodies, one commonly used antibody to
detect neutrophils and monocyte/macrophages (Sabroe et al.,
2002). The C population cells were stained by the
neutrophil-specific CD66B antibodies (56.2%) as well asFig. 3. Migration induced by TMEV-infected undiluted mouse astrocyte
supernatant (0) and the effect of neutralizing antibodies against the CXCL1
chemokine on chemotaxis of human buffy coat cells. Different amounts of
antibody (3, 30 and 60 μg) were studied for its capacity to inhibit migration. The
number of chemoattracted cells was determined by flow cytometry. The positive
migration control was induced by SDF-1α (SDF) at a concentration of 100 ng/ml
and (−) was the unspecific migration of the cells towards culture medium in the
lower compartment of the transwell chamber. Data represent the mean±SD of
triplicate samples. *Significant differences with the unspecific migration control
group were determined by the Student's t test (P<0.01).the B population cells (8%). Hence, we assume that B
population is composed of 8% neutrophils and of 85% (93–
8) monocyte/macrophages. C population, having of a fewer
number of cells, is therefore composed of 56% neutrophils
and 37% (93–56) monocyte/macrophages (Fig. 4).
CXCL1 induction by inflammatory cytokines
Four recombinant inflammatory cytokines (IL-1α, IL-6,
IFN-γ and TNF-α) were tested for their possible role in the
upregulation of CXCL1 in SJL/J astrocytes. As shown in Fig.
5A, neither IL-6 nor IFN-γ upregulated chemokine production
by astrocytes. Conversely, IL-1α and TNF-α (at a concentration
of 10 ng/ml) increased the release of CXCL1 to the cultures
supernatants to levels of 20 and 7 ng/ml respectively. To
determine the minimal dose of cytokines required for CXCL1
induction, astrocytes were incubated with 1, 10 and 100 ng/ml,
showing that CXCL1 was readily detected after stimulation
with 1 ng/ml of both IL-1α and TNF-α, whereas IL-6 and IFN-
γ were always found negative (not shown). The ELISA used
(QuantikineR M mouse KC assay) has no significant cross-
reactivity with any of the four inflammatory cytokines studied
here. As both IL-1α and TNF-α may be an important stimulus
for CXCL1 autocrine expression in vitro, we tested neutralizing
antibodies against both cytokines on TMEV-induced upregula-
tion (Figs. 5B and C). A very weak reduction of the levels of
CXCL1 chemokine in the supernatants either at 48 or 24 h after
infection was detected, even at concentrations of 100 μg/ml of
both neutralizing antibodies in the culture medium. We obtained
the same negative results when both antibodies were added
together to the cultures (not shown). Therefore, both chemokine
and cytokine induction by TMEV seems to follow independent
pathways.
MAP kinase inhibition
Several viruses trigger activation of the mitogen-activated
proteins (MAP) kinase phosphorylation pathway, which is
involved in the control of host cell proliferation and survival.
Based on the reported role of the MAP kinase pathway in
mediating human IL-8 production, MAP/ERK kinase inhibitor
PD98059 was added to astrocyte cultures before TMEV
infection at concentrations that block IL-8 synthesis. As
shown in Fig. 6, the inhibitor did not reduce CXCL1 production
in a significant way even at PD98059 concentrations of 100 μM,
when it induces 88% inhibition of IL-8 production in human T
cells at a concentration of 12.5 μM (Harris et al., 2002). In order
to check if MAP/ERK-related transcripts were changed in
TMEV-infected astrocytes, we studied the transcripts with a
SCOP database description of MAP kinases, in the data
analysis provided by the DNA array hybridization results. As a
matter of fact, the SCOP family “d.144.1.1:MAP kinase Erk2”
includes seven transcripts that are clearly decreased and only
one that is increased (Table 2). This means that TMEV induces
in astrocytes a decrease of overall MAP kinase activity that
agreed with the results from Fig. 6 and that the induction of
CXCL1 is not mediated by the MAP/ERK kinase pathway. The
Fig. 4. Cytofluorometric analysis of the human cells chemoattracted by astrocyte supernatants. The CD3, CD11b and CD66b profile of the three significant migrating
cell populations (A–C) was studied. Population A was mainly induced by SDF-1α and populations B and C were mainly induced by TMEV-infected astrocytic
supernatants. The relative percent of stained cells were indicated in the upper right corner of each quadrant followed by the mean fluorescence intensity (in
parentheses). Negative controls were stained with an irrelevant antibody (P3X63 mAb). The figure shows a representative result of three separate experiments.
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produced a normal amount of 22±5×105 PFU/ml at 100 μM
PD98059 concentration, compared with 21±7×105 PFU/ml in
the absence of inhibitor. Neither cell viability was affected at the
higher concentration of inhibitor used, as determined by 0.4%
Trypan blue staining (not shown).
Intracranial TMEV infection induces CXCL1 in SJL/J mice
We investigated the pathological relevance of our findings in
this experimental model of multiple sclerosis, measuring the
levels of CXCL1 in SJL/J and BALB/c mice using 10%
homogenates of brains and spinal cords from animals infected
intracerebrally with the BeAn strain of TMEV. All brain
homogenates were consistently found negative in the ELISA
test but a significant peak (P<0.01) of CXCL1 in spinal cord
(800–900 pg/ml) was detected by days 11–13 after TMEV
injection, decreasing thereafter to negative background levels
(Fig. 7). This time corresponds to the start of clinical signs of
demyelination, particularly the chronic gait abnormality and
spasticity (Lipton, 1975, Clatch et al.,1986). It also corresponds
to the expression of several chemokines mRNAs in SJL/J spinal
cords, detected by RT-PCR (Hoffman et al., 1999). All nervoustissues from untreated or TMEV-injected BALB/c mice were
consistently found negative.
Discussion
Astrocytes play an important role in the immune response
that triggers demyelination after intracerebral infection by the
TMEV low-neurovirulence BeAn viral strain. This demyelinat-
ing process is currently used as an experimental model for MS.
It has been proposed that cytokines and chemokines released in
the site of TMEV infection lead to recruitment and accumula-
tion of virus-specific CD4+ T cells, monocyte/macrophages,
neutrophils and other immune cells in the CNS. Those cells
would cause demyelination by a nonspecific bystander response
resulting in stripping of myelin lamellae (Clatch et al., 1986).
Using hybridization to the U74v2 DNA microchip array
from Affymetrix, we demonstrated the overexpression of genes
homologous to the human IL-8 family in murine astrocytes
infected with the BeAn virus. Despite the possible presence of
other chemokines in those supernatants, we focused on the most
prominent member of the CXC mouse chemokine family, the
CXCL1 or KC chemokine, quantifying and characterizing its
chemoattractant biological activity. Our GeneChip microarray
Fig. 5. Induction of CXCL1 in astrocytes by inflammatory cytokines. In panel
A, astrocytic cultures were untreated (−) or treated with 10 ng/ml each of
recombinant IL-1α, IL-6, IFN-γ and TNF-α for 48 h. Supernatants were then
centrifuged and tested for the presence of CXCL1 by ELISA. In panels B and C,
astrocytes in 6-well multiwell plates were infected with TMEVat an m.o.i. of 10
for 1 h at room temperature, washed and then incubated for either 24 or 48 h in
medium containing different amounts of anti-IL-1α or anti-TNF-α purified
neutralizing antibodies. Supernatants were further tested for CXCL1 by ELISA.
Data represent the mean±SD of triplicate samples. Significant differences with
the untreated control groups as determined by the Student's t test (P<0.01) * or
(P<0.05) **.
Fig. 6. Lack of inhibition of CXCL1 production in cultures of astrocytes infected
with TMEV by the MAP/ERK kinase inhibitor PD98059. Cells were pretreated
for 2 h at 37 °C with 1, 10 or 100 μM PD98059, washed and infected with
TMEV at an m.o.i. of 1. Supernatants were tested for CXCL1 production 24 h
later by ELISA. CXCL1 production by cultures infected but not treated with the
inhibitor (0) was shown for comparison. Data represent the mean±SD of
triplicate samples.
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MIG (CXCL9), with a mean fold increase of 13.0, IP-10
(CXCL10) (fold increase of 10.4) and MIP-2 (CXCL2) (fold
increase of 10.2). The 14.3-fold increase in expression of
CXCL1 is therefore somewhat higher than that found for the
above chemokines.
Two genes coding for a melanome growth-stimulating
activity or GRO 1 were overexpressed after TMEV infection
(Table 1), and the CXCL1 gene is the murine homologue of this
human gene (Oquendo et al.,1989). The Gene Ontology
notation indicated that the products of those genes were
extracellular and, as a matter of fact, the CXCL1 chemokine
is released to the culture medium by infected astrocytes and can
be detected and quantified by a specific ELISA. CXCL1
released to tissue culture supernatants is also biologically active
in a non-species-specific way as it attracts human buffy coat
neutrophils and monocyte/macrophages, but not CD3+ T
lymphocytes. This fact stresses the usefulness of our experi-
mental model for human MS. CXCL1 induction is independentTable 2
Changes in the expression of transcripts with description of SCOP family of
“d.144.1.1:MAP kinase Erk2” in TMEV-infected astrocytes
Affymetrix
sequence
Sham-infected
astrocytes
signal
TMEV-infected
astrocytes
signal
Signal
log ratio
Fold
change
Chromosome
location
Increased transcripts
97,106 at 2.8 67.0 4.4 8.8 –
Decreased transcripts
97,094 at 29.1 4.3 −2.3 −4.6 #5
99,459 f at 31.0 8.2 −1.7 −3.4 #19
100,128 at 200.6 108.0 −1.2 −2.4 #10
100,155 at 976.5 660.3 −0.8 −1.6 #17
102,195 at 79.1 64.9 −0.8 −1.6 –
102,827 at 358.8 251.6 −0.5 −1 #1
93,253 at 135.9 107.9 −0.3 −0.6 #16
Fig. 7. CXCL1 contents in brain and spinal cord homogenates in SJL/J mice
infected intracranially with 2×10 6 PFU of TMEV. The 10% homogenates were
tested in the CXCL1 ELISA test, and results represented corrected to 100%
values. Data represent the mean±SD of three individual samples. *Significant
differences with the untreated control groups as determined by the Student's t
test (P<0.01).
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ERK-kinase specific inhibitor PD98059.
mRNA specific for CXCL1 has been demonstrated in TMEV-
infected astrocytes, validating the DNA microarray hybridiza-
tion results (Fig. 1). Our DNA hybridization results are
consistent with previous reports of the detection of increases
in several chemokine mRNAs, including those coding for IP-10,
by RNase protection or RT-PCR assays in TMEV-infected
astrocytes (Palma and Kim, 2001, 2004). The presence of
several chemokines in the CNS of the experimental autoimmune
encephalomyelitis (EAE) mice, another T-cell-mediated model
for MS, as well as in the brain of patients affected by MS itself,
has been recently reviewed (Bajetto et al., 2002).
We also report the induction of CXCL1 expression by
astrocytes treated by cytokines usually involved in immune
mediated inflammatory processes, including IL-1α and TNF-α,
but not by others as IL-6 and IFN-γ (Beutler and Cerami, 1987;
Dinarello., 1989; Kishimoto, 1989). Previously published
results from our laboratory report that BeAn virus induces
TNF-α and IL-1α in SJL/J astrocytes, but not in BALB/c
astrocytes (Rubio and Capa, 1993; Sierra and Rubio, 1993). The
peak of TNF-α release to the culture medium was reported to be
reached after 24 h (Sierra and Rubio, 1993) and that of IL-1α
after 12 h (Rubio and Capa, 1993). As maximal CXCL1
production is detected 48 h post-infection (Fig. 2), the induction
of the two cytokines precedes the overexpression of the
chemokine, suggesting some overlapping. In our hands,
neutralizing antibodies against IL-1α and TNF-α fail to reduce
TMEV-induced CXCL1 production (Figs. 5B and C), indicating
that in this model the induction of chemokines and cytokines
follows distinct temporal patterns and pathways. Conversely,
the injection of anti-IL-1α antibodies intradermally in mice after
surgical injury has been reported to block the production of
CXCL1 and MIP-2 by 50% (Wiekowski et al., 2001). Anothervarious stimuli have been demonstrated to induce CXCL1
chemokine gene expression as surgical injury in vivo (Endlich
et al., 2002) or treatment of dendritic cells with other chemokine
as RANTES (CCL5) (Fischer et al., 2001).
Multiple unlinked genes are actually involved in mouse
strain susceptibility to TMEV-induced demyelination. So far,
one is located in the H-2D region (Clatch et al., 1985) and others
map in chromosomes 3, 6 and 11 (Melvold et al., 1987; Melvold
et al., 1990; Aubagnac et al., 1999). According with our Gene
Chip analysis, overexpressed CXCL1 genes were located in
mouse chromosome number 5 (Table 1). Nevertheless, we
propose that CXCL1 produced intracranially by astrocytes is
one of the chemokines used for the recruitment and influx of
neutrophils and monocyte/macrophages inside the CNS after
TMEV infection. Those phagocytic cell types migrate to
inflamed sites during the immune response and possess a
battery of enzymes that can damage myelin.
Interestingly, we have detected CXCL1 in the spinal cord of
the susceptible SJL/J, but not in resistant TMEV-infected
BALB/c strains, during the acute phase of the disease due to
encephalitis (Fig. 7). The chemokine could be produced, in
addition to other cell types of the CNS, by astrocytes of the gray
and white matter of the spinal cord that also contains abundant
virus detected by immunohistochemical methods from 7 to 10
days onward after infection (Dal Canto and Lipton, 1982). The
fact that CXCL1 expression was detected in spinal cord but not
in brain homogenates must be explained by the fact that BeAn
virus replication peak in the brain on day 5 and decline 1000-
fold by days 11 to 13 post-infection. This decrease is accom-
panied by increase of 50- to 100-fold (P<0.005) in viral RNA
copy numbers in spinal cords starting on day 11, as determined
by real-time RT-PCR (Trottier et al., 2004). The same authors
detect the presence of the chemokine RANTES (CCL5) in brain
tissue that decreases to low levels after 7–9 days post-infection
(Trottier et al., 2004).
Therefore, a direct implication of CXCL1 in the
chemoattraction of destructive neutrophils and monocyte/
macrophages that form, in addition to T cells, the character-
istic infiltrates in areas of demyelination is proposed. CD3
positive encephalitogenic T lymphocytes could be chemoat-
tracted by other chemokines, mainly RANTES (CCL5) and
IP-10 (CXCL10), also found in the CNS during the TMEV-
induced disease. Transgenic models have been developed in
mice for the study of upregulation of CXCL1 in several
tissues (Lira et al., 1994) or specifically in the lung (Tsai et
al., 1998) and the CNS (Tani et al., 1996). In this case, a
remarkable infiltration of neutrophils in the brain was
demonstrated followed by a neurological syndrome of
postural instability and spasticity (Tani et al., 1996). Those
models confirm the in vivo chemoattractant properties of
CXCL1 for neutrophils and other polymorphonuclear cells.
The presence of CXCL1 in the spinal cords of TMEV-
susceptible but its absence in TMEV-resistant strains of mice
during the acute phase of the disease could correlate with the
influx of immune cells into the CNS, which can induce a
bystander response resulting in myelin breakdown. The
novelty of the strain-dependent expression of CXCL1 both
105N. Rubio, F. Sanz-Rodriguez / Virology 358 (2007) 98–108in vivo and in vitro reported by us is therefore the central
focus of interest in this article. Very recently, it was reported
that CXCL1 is specifically upregulated in astrocytes from
active MS lesions (Omari et al., 2005). Our findings produce
some insights into the regulation of immune cell trafficking in
inflammatory conditions in the CNS and identify potential
therapeutic targets by limiting cell infiltration in MS.
Materials and methods
Astrocyte cultures
Astrocyte cultures were prepared by mechanical dissocia-
tion of the cerebral cortex from newborn SJL/J and BALB/c
Cum mice (Rubio et al., 2003). The cortex was isolated under
a dissecting microscope and cleaned of choroid plexus and
meninges. Cell suspensions were filtered through 135-μm
pore size mesh into Dulbecco's modified Eagle medium
(DMEM) containing 10% fetal calf serum (FCS) and
penicillin–streptomycin (Gibco BRL, Paisley, Scotland).
After centrifugation, cells were filtered through a 40 μm
nylon cell strainer (Falcon-Becton Dickinson, Le Pont De
Claix, France) and cultured in 75-cm2 tissue culture flasks
(Costar, Cambridge, MA) at 37 °C. The medium was changed
after 4 days in culture and subsequently 2 times a week for
the entire culture period. Cultures were enriched for astrocytes
by the removal of less adherent microglia and oligodendro-
cytes by shaking overnight at 37 °C at 250 rpm in a table top
shaker (Thermo Forma, Marietta, OH). Cellular confluence
was observed 10 days after plating, producing around 1×107
cells per flask and showing a polygonal flat morphology. A
mean of 98% astrocytes was confirmed by indirect immuno-
fluorescence staining of methanol-fixed cultures using rabbit
anti-glial fibrillar acidic protein (GFAP) antiserum (Dakopatts,
Glostrup, Denmark). The lack of noticeable mature oligoden-
drocytes or microglial/macrophage cells was determined using
a guinea pig anti-myelin basic protein (MBP) antiserum
prepared as described elsewhere (Rubio and Cuesta, 1989)
and monoclonal anti-Mac-1 antibody (Serotec, Oxford, UK).
Secondary fluorescein-labeled antibodies were purchased
from Sigma Chemical Co (St. Louis, MO).
Viruses and infection
For these studies, a strain of TMEV isolated in 1957 from
a feral mouse in Belem, Brazil, called BeAn 8386, was used.
Baby hamster kidney cells (BHK-21) were grown at 37 °C in
DMEM containing 10% FCS and penicillin–streptomycin.
BHK-21 cell cultures were infected for 48 h at 33 °C,
sonicated and centrifuged in the cold to remove cells debris.
Virus titer (108 plaque-forming units (PFU)/ml) was deter-
mined by a standard plaque assay on BHK-21 cells with 1%
Noble agar (Difco Laboratories, Detroit, MI) and staining
with 0.2% crystal violet in 20% methanol. Purified astrocytes
in 75-cm2 tissue culture flasks were infected with BeAn virus
at several multiplicities of infection (m.o.i.) in a volume of
10 ml of DMEM containing 0.1% BSA, at room temperaturefor 1 h. After infection, cells were washed, 10 ml of DMEM
plus 10% FCS was added and flasks were incubated at 37 °C
for different periods of time. No changes in cell viability, as
determined by 0.4% Trypan blue (Gibco BRL) uptake, nor
cytopathic effect or loss of normal morphology under the
microscope were detected after infection with BeAn virus,
although the percentage of infected cells is almost 100%
(Zheng et al., 2001). Cells used for mock infections were
incubated with a virus-free BHK-21 cell lysate. For UV light-
virus inactivation, viral samples were irradiated at 560 μW/
cm2 for 15 min. These conditions produced inactivated virus
stocks devoid of infectious virus, as determined by plaque
assay (<10 PFU/ml).
cRNA target preparation and hybridization
Three different SJL/J astrocyte cultures infected at an m.o.i.
of 10 were harvested 24 h post-infection, washed with
phosphate-buffered saline and total RNA was isolated by
using the TRIzol reagent (Gibco BRL) followed by a further
purification with RNeasy Mini Kit (Qiagen, Valencia, CA).
Ten micrograms of RNA was converted to cDNA by using
the kit SuperScript Choice System (Gibco BRL). Second-
strand synthesis was performed using T4 DNA polymerase,
and cDNA was isolated by phenol-chloroform extraction.
Isolated cDNA was transcribed using the BioArray High
Yield RNA transcript Labeling Kit (Enzo Biochem, New
York, NY) with biotin-labeled UTP and CTP to produce
biotin-labeled cRNA. Labeled cRNA was isolated using the
RNeasy Mini Kit and fragmented in 100 mM potassium
acetate–30 mM magnesium acetate–40 mM Tris–acetate (pH
8.1) for 30 min at 94 °C. Hybridization performance was
analyzed using Test 2 arrays (Affymetrix, Santa Clara, CA)
and spike and housekeeping controls. Target cRNA was
hybridized to the murine genome U74v2 microarray (Affy-
metrix) according to manufacturer's protocols. Briefly, 15 μg
of fragmented cRNA was hybridized for 16 h at 45 °C with
constant rotation (60 rpm). The microarrays were washed and
stained with streptavidin-conjugated phycoerythrin (SAPE)
using the Affymetrix GeneChip Fluidic Station 400. All
hybridization steps were performed by Medplant Genetics
Inc. (Barakaldo, Spain).
Data analysis
Each gene on the U74v2 array is represented by 20
different 25-base cDNA oligonucleotides complementary to a
cRNA target transcript (perfect match). As a hybridization
specificity control, an oligonucleotide containing a single
base substitution corresponding to each perfect-match cDNA
oligonucleotide (mismatch) is represented on the array. The
combination of perfect-match and mismatch cDNA oligonu-
cleotides for each gene is termed a probe set. By using
Affymetrix-defined absolute mathematical algorithms describ-
ing perfect-match and mismatch intensities, each gene was
defined as absent or present and assigned a value. Binding
intensity values were scaled to evaluate differential
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metrix-defined comparison mathematical algorithms, a virus-
induced transcript was classified as unchanged, marginally
increased, marginally decreased, increased or decreased. The
changes were quantified by the signal log ratio correspond-
ing to the log2 of the fold change for each gene. Standard
errors in mean transcriptional expression of a gene were also
calculated.
Northern blot analysis
Confluent monolayers of purified astrocytes were infected
with TMEV as previously stated. Total RNA was purified
using the RNeasy Mini Purification kit (Qiagen). Ten
micrograms per lane was electrophoresed on a formalde-
hyde–agarose gel and transferred to nylon membranes (Zeta-
Probe, Bio-Rad Laboratories, Hercules, CA) and probed in
Rapid-hyb buffer (Amersham Biosciences). The probe used
was the 25-base oligonucleotide 5′-cacagctttcccgtggactttcctt-3′
specific for mouse CXCL1 mRNA (NCBI accession number
S79767; base numbers 801–825) synthesized by Sigma-
Genosys Ltd. (Cambridgshire, UK). The probe was labeled
with (γ-32P)ATP (Amersham Biosciences) using Ready-To-
Go T4 polynucleotide kinase (Amersham Pharmacia Biotech).
Unincorporated radiolabel was removed on Micro-Spin G-50
columns (Amersham Pharmacia Biotech). Blots were exposed
to Kodak X-OMAT film with an intensifying screen at
−80 °C. Hybridization to a human β-actin probe (Clontech,
Palo Alto, CA) served as an internal control for loading. The
probe was labeled with (32P)dCTP using the random-primed
method (Boehringer Mannheim, Germany). Unincorporated
radiolabel was removed on S-300 Micro-Spin columns.
Chemokine assay
CXCL1 concentrations in cell culture supernatants and
mouse CNS were determined using the QuantiquineR M
mouse KC ELISA immunoassay (R&D Systems, Minneapo-
lis, MN). This kit has a sensitivity of 2 pg/ml with no
significant cross-reactivity with MIP-2 or other mouse
chemokines observed. For flow cytometric analysis of
intracellular CXCL1 staining, mock- and TMEV-infected
(m.o.i. of 10, 48 h infection) astrocyte cultures were detached
from the flasks with Versene (Gibco BRL) and cell
membranes permeabilized with 0.3% Saponin (Sigma) in
PBS–1% FCS, for 5 min at room temperature. Cells were
washed one time by centrifugation with PBS–1% FCS, 0.2%
sodium azide (Sigma) and 0.1% Saponin and incubated with
anti-KC goat IgG antibodies (R&D Systems). After two
washes, cells were incubated with the secondary FITC-
conjugated rabbit anti-goat antibody (Sigma) diluted 1:200, in
the same conditions as above. After three more washes, cells
were fixed in 1% paraformaldehyde and analyzed in a
FACSCalibur flow cytometer (Becton Dickinson Biosciences,
Palo Alto, CA). Data from 10,000 cells were collected and
evaluated using the CellQuest 3.1f software supplied with the
instrument.Migration assay and FACS cell characterization
Venous blood from healthy adult volunteers was collected
into EDTA-containing tubes. Circulating cells were isolated
by Ficoll density centrifugation (Pharmacia Biotech, Uppsala,
Sweden) and washed twice in medium to remove residual
EDTA. Cell viability was assessed by Trypan blue exclusion
and was invariably >98%. Chemotactic assays were con-
ducted in the upper chamber of transwell chambers (3-μm
pore size membrane) (Costar, Cambridge, MA). Briefly, each
upper chamber was loaded with 25,000 cells in a total volume
of 500 μl of DMEM plus 0.5% BSA medium (600 μl).
Different dilutions of TMEV-infected astrocyte cultures
medium were added to the lower chamber and transwells
were incubated at 37 °C in a 5% CO2 atmosphere for 3 h.
Cells were collected from the bottom compartment, centri-
fuged, resuspended and quantified using a flow cytometer
(Coulter EPICS-XL). The positive controls contained in the
lower chamber 100 ng/ml stromal cell-derived factor-1α
(SDF-1α) (Calbiochem, La Jolla, CA) and the negative
controls DMEM plus 0.5% BSA medium. Cell characteriza-
tion was assessed by flow cytometry using (1) anti-CD3
antibody for T lymphocyte, (2) anti-CD11b antibody for
neutrophil–monocyte/macrophages and (3) anti-CD66b for
granulocyte–neutrophil staining. An irrelevant P3X63 mAb
was used for negative control staining. All antibodies were
from BD Biosciences-Pharmingen, San Diego, CA. In the
chemokine neutralization experiments, 1-ml aliquots of super-
natants were incubated with different amounts of purified
anti-KC goat IgG antibodies (R&D Systems) for 1 h at 37 °C
followed by 2 h at 4 °C and then tested in the migration
assay.
MAP kinase inhibitor and proinflammatory cytokines
treatments
Astrocyte cultures were pretreated with 1–100 μM of the
mitogen-activated protein (MAP)/extracellular signaling
kinase (ERK)-specific inhibitor PD98059 (New England
Biolabs, Beverly, MA) for 2 h at 37 °C, washed and infected
with TMEV as previously stated. In another series of
experiments, cells were treated for 48 h with 10 ng/ml of
the following mouse recombinant proinflammatory cytokines:
mouse recombinant IL-1α (Genzyme, Cambridge, MA); rIFN-γ
of murine origin (Holland Biotechnology, Leiden, The Nether-
lands); recombinant murine tumor necrosis factor-α (TNF-α)
(Innogenetics, Antwerp, Belgium); and rIL-6 (Boehringer
Mannheim, Germany). To test antibodies against IL-1α and
TNFα, astrocytes were trypsinized from 75 cm2 flasks to 6-well
multiwell plates (Costar) and infected for 1 h at room
temperature with TMEV at an m.o.i. of 10. After washing, the
cultures were incubated for 24 or 48 h in 2 ml of complete
medium per well, containing 1, 10 or 100 μg of the IgG fraction
of goat antiserum against mouse IL-1α or goat affinity isolated
antibodies anti-TNF-α, both from Sigma. After this periods of
time, centrifugated supernatants were tested for the presence of
CXCL1 by ELISA.
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Six-week-old SJL/J and BALB/c mice were purchased from
The Jackson Laboratory, Bar Harbor, ME and maintained on
standard feed and water ad libitum at the Instituto Cajal. Mice
were anesthetized with fluorthane and injections made using a
25-μl Hamilton syringe in the right cerebral hemisphere.
Twenty microliters of a suspension of BeAn virus (2×106
PFU) was injected per animal. Brains and spinal cords were
harvested and homogenized at 10% in DMEM using a Poly-
tron homogenizer (model PT 10–35) at setting 3, for 15 s. The
homogenates were centrifuged for 10 min at 500×g and tested
in the ELISA test. Clinical disease signs, including (1)
spasticity and (2) gait abnormalities, indicative of demyelina-
tion, were scored three times per week after intracerebral inocu-
lations (Lipton, 1975).References
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